An old intravenous antibiotic may have new life as a stroke treatment, researchers say. Minocycline appears to reduce stroke damage in multiple ways — inhibiting white blood cells and enzymes that, at least acutely, can destroy brain tissue and blood vessels, respectively, say researchers. The broad-spectrum antibiotic also seems to reduce cell suicide in the minutes and hours following a stroke, enabling more cells to recover.